Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 19 studies | 36% ± 16% | |
classical monocyte | 16 studies | 39% ± 14% | |
monocyte | 15 studies | 27% ± 8% | |
microglial cell | 7 studies | 30% ± 14% | |
myeloid cell | 6 studies | 31% ± 13% | |
conventional dendritic cell | 5 studies | 35% ± 16% | |
dendritic cell | 5 studies | 25% ± 12% | |
hematopoietic precursor cell | 4 studies | 33% ± 17% | |
macrophage | 4 studies | 18% ± 1% | |
alveolar macrophage | 4 studies | 26% ± 6% | |
common myeloid progenitor | 3 studies | 29% ± 7% | |
hematopoietic stem cell | 3 studies | 30% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 264.68 | 2454 / 2642 | 98% | 8.64 | 694 / 705 |
prostate | 97% | 416.12 | 238 / 245 | 93% | 2.77 | 467 / 502 |
thymus | 97% | 202.75 | 636 / 653 | 92% | 3.45 | 554 / 605 |
lung | 100% | 1208.47 | 578 / 578 | 88% | 4.13 | 1014 / 1155 |
uterus | 97% | 186.17 | 165 / 170 | 76% | 2.07 | 348 / 459 |
ovary | 93% | 151.79 | 168 / 180 | 78% | 2.22 | 335 / 430 |
breast | 83% | 142.75 | 379 / 459 | 84% | 2.57 | 939 / 1118 |
kidney | 70% | 112.09 | 62 / 89 | 90% | 4.99 | 812 / 901 |
adrenal gland | 95% | 173.12 | 245 / 258 | 50% | 0.98 | 116 / 230 |
intestine | 83% | 120.45 | 803 / 966 | 57% | 1.52 | 303 / 527 |
bladder | 76% | 117.86 | 16 / 21 | 58% | 1.77 | 294 / 504 |
skin | 67% | 101.17 | 1215 / 1809 | 64% | 2.43 | 304 / 472 |
liver | 96% | 199.69 | 216 / 226 | 35% | 0.85 | 143 / 406 |
pancreas | 39% | 63.57 | 128 / 328 | 90% | 5.52 | 160 / 178 |
stomach | 50% | 61.85 | 179 / 359 | 70% | 1.91 | 201 / 286 |
esophagus | 53% | 62.44 | 772 / 1445 | 58% | 1.39 | 107 / 183 |
lymph node | 0% | 0 | 0 / 0 | 100% | 5.55 | 29 / 29 |
spleen | 100% | 1663.81 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 87% | 181.24 | 1048 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 4885.81 | 765 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 3.39 | 37 / 45 |
blood vessel | 58% | 89.50 | 770 / 1335 | 0% | 0 | 0 / 0 |
heart | 33% | 42.15 | 280 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 30% | 0.54 | 24 / 80 |
muscle | 4% | 3.67 | 32 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043313 | Biological process | regulation of neutrophil degranulation |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
GO_0008289 | Molecular function | lipid binding |
Gene name | PRAM1 |
Protein name | PML-RARA-regulated adapter molecule 1 (PRAM) (PRAM-1) PML-RARA regulated adaptor molecule 1 |
Synonyms | |
Description | FUNCTION: May be involved in myeloid differentiation. May be involved in integrin signaling in neutrophils. Binds to PtdIns(4)P. |
Accessions | ENST00000423345.5 ENST00000600262.1 M0R149 Q96QH2 |